NSE · Basic Materials · Specialty Chemicals
EPS came in at 9.17 against a street estimate of 7.10 — a beat of 29.2%.
with an average price target of ₹1,550.00.
| Holder | Stake |
|---|---|
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | 2.59% |
| Nippon Life India Trustee Ltd-A/C Nippon India Elss Tax Saver Fund | 2.21% |
| Mukul Mahavir Agrawal | 2.14% |
| Document | Date |
|---|---|
| Annual report FY2026 TATVA CHINTAN PHARMA CHEM LIMITED – FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹4,962.96 million (FY 2025-26) vs ₹3,664.15 milli | 2026-08-27 |
| Q1 FY27 earnings call TATVA CHINTAN PHARMA CHEM LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Operating revenue: INR 1,671 million in Q1 FY27, up 43% year-on-year and 25% | 2026-07-21 |
| Investor presentation · Q1 FY27 TATVA CHINTAN PHARMA CHEM LIMITED - Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY27 Revenue: ₹1,671 Mn, up 43% YoY (Q1 FY26: ₹1,169 Mn) • Q1 FY2 | 2026-07-17 |
| Quarterly results · Q1 FY27 TATVA CHINTAN PHARMA CHEM LIMITED – INVESTOR SUMMARY Q1 FY2026-27 Results (Quarter ended 30 June 2026) --- HEADLINE NUMBERS CONSOLIDATED RESULTS (Q | 2026-07-17 |
| Q4 FY26 earnings call TATVA CHINTAN PHARMA CHEM LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Q4 FY26 Operating Revenue: INR 1,341 million – 24% YoY growth, 2% QoQ growth | 2026-05-19 |
| Investor presentation · Q4 FY26 TATVA CHINTAN PHARMA CHEM LIMITED - INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue from Operations: ₹5,059 Mn (up 32% YoY from ₹3,827 Mn in FY25) | 2026-05-16 |
| Quarterly results · Q4 FY26 TATVA CHINTAN PHARMA CHEM LIMITED — INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from operations (FY 2025-26): Rs 5,058.58 million • Net profit after | 2026-05-16 |
| Q3 FY26 earnings call TATVA CHINTAN PHARMA CHEM LIMITED – Q3 FY'26 SUMMARY HEADLINE NUMBERS • Q3 FY2026 Operating Revenue: INR 1,313 million (53% YoY growth, 6% sequentia | 2026-01-24 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹2 / share ex-date Sep 11, 2026 | 2026-09-11 |
| Announcement | Date |
|---|---|
| Capacity addition announced for manufacturing operations Tatva Chintan Pharma Chem Limited has informed the Exchange about Capacity addition | 2026-07-17 |
| Acquisition announced Tatva Chintan Pharma Chem Limited has informed the Exchange about Acquisition | 2026-02-18 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tatva Chintan Pharma Chem Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.